Related Experiment Videos
Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological
Insights
Intravenous nifedipine did not affect atrioventricular conduction in patients. Verapamil, however, demonstrated antiarrhythmic effects by slowing conduction, suggesting differential calcium channel antagonist actions.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Calcium antagonists are crucial in managing cardiovascular conditions.
- Understanding the differential effects of these drugs on cardiac conduction is vital for patient safety.
Purpose of the Study:
- To investigate the effects of intravenous nifedipine on atrioventricular (AV) conduction.
- To compare the electrophysiological effects of nifedipine with verapamil.
Main Methods:
- Electrophysiological studies were conducted on 11 patients.
- Intravenous administration of nifedipine and verapamil was performed during these studies.
Main Results:
- Nifedipine showed no significant impact on atrioventricular conduction.
- Verapamil exhibited potent antiarrhythmic properties, notably depressing atrioventricular nodal conduction.
Conclusions:
- Nifedipine is likely safe for patients with angina and AV nodal conduction disorders or those on beta-blockers.
- Different calcium antagonists appear to have distinct effects on cardiac slow inward channels.
Abstract:
Intravenous nifedipine, a powerful calcium antagonist, had no obvious effect on atrioventricular conduction when administered to 11 patients during routine intracardiac electrophysiological studies. Verapamil on the other hand showed potent antiarrhythmic properties, depressing atrioventricular nodal conduction. Nifedipine thus appears safe in patients with angina pectoris who have disorders of atrioventricular nodal conduction, and in those receiving beta-adrenergic blocking drugs. There appear to be differential effects on the slow inward channels of cardiac cells with different 'calcium antagonists'.